{"id":8169,"date":"2023-05-05T02:33:32","date_gmt":"2023-05-04T23:33:32","guid":{"rendered":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/"},"modified":"2023-05-23T17:37:30","modified_gmt":"2023-05-23T14:37:30","slug":"premier-vaccin-rsv-approuve-apres-six-decennies-dimportantes-realisations-en-matiere-de-sante-publique","status":"publish","type":"post","link":"https:\/\/urbancare.clinic\/fr\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/","title":{"rendered":"Approbation du premier vaccin contre le VRS apr\u00e8s six d\u00e9cennies\u00a0: \u00ab\u00a0r\u00e9alisation importante en mati\u00e8re de sant\u00e9 publique\u00a0\u00bb"},"content":{"rendered":"

Un \u00e9v\u00e9nement monumental dans l'histoire du secteur de la sant\u00e9 s'est produit cette semaine apr\u00e8s que la Food and Drug Administration (FDA) des \u00c9tats-Unis a approuv\u00e9 le tout premier vaccin contre le VRS pour les personnes \u00e2g\u00e9es, dont la fabrication a pris six d\u00e9cennies.<\/p>\n

Mercredi, la FDA a officiellement approuv\u00e9 le vaccin contre le RSV que les scientifiques ont travaill\u00e9 dur pour d\u00e9velopper au cours des soixante derni\u00e8res ann\u00e9es, les pr\u00e9c\u00e9dentes tentatives tr\u00e8s m\u00e9diatis\u00e9es n'ayant pas vu le jour. Actualit\u00e9s ABC<\/a> signal\u00e9.<\/p>\n

GSK a d\u00e9velopp\u00e9 le premier vaccin contre le RSV approuv\u00e9 pour les personnes \u00e2g\u00e9es, Arexvy. Le groupe pharmaceutique a d\u00e9clar\u00e9 disposer d\u00e9j\u00e0 de \u00ab millions de doses pr\u00eates \u00e0 \u00eatre exp\u00e9di\u00e9es \u00bb en attendant la recommandation des Centres de contr\u00f4le et de pr\u00e9vention des maladies (CDC), attendue en juin.<\/p>\n

GSK a d\u00e9clar\u00e9 qu'il disposerait de suffisamment de doses de vaccin pour r\u00e9pondre \u00e0 la demande au moment o\u00f9 la maladie respiratoire deviendrait r\u00e9pandue au cours des saisons d'automne et d'hiver. Mais il convient de noter que Pfizer et Moderna travaillent \u00e9galement sur des vaccins similaires. Les deux pourraient \u00e9galement rejoindre le march\u00e9 peu de temps apr\u00e8s avoir re\u00e7u l\u2019approbation de la FDA.<\/p>\n

Le vaccin de Moderna est d\u00e9j\u00e0 en phase 3 d'essai. Une fois cela fait, il soumettra les r\u00e9sultats \u00e0 la FDA et attendra son approbation. Pendant ce temps, le vaccin RSV de Pfizer est d\u00e9j\u00e0 termin\u00e9. Elle n'attend plus que la d\u00e9cision de la FDA, qui pourrait \u00eatre rendue d'ici fin mai.<\/p>\n

Arexvy est con\u00e7u pour \u00eatre administr\u00e9 en une seule injection aux adultes \u00e2g\u00e9s de 60 ans et plus. Le directeur du Centre d'\u00e9valuation et de recherche sur les produits biologiques de la FDA, le Dr Peter Marks, a expliqu\u00e9 qu'il est crucial pour les personnes \u00e2g\u00e9es de recevoir ce vaccin, car elles courent un risque \u00e9lev\u00e9 de souffrir de maladies graves une fois qu'elles contractent le virus.<\/p>\n

"Les personnes \u00e2g\u00e9es, en particulier celles souffrant de probl\u00e8mes de sant\u00e9 sous-jacents, tels qu'une maladie cardiaque ou pulmonaire ou un syst\u00e8me immunitaire affaibli, courent un risque \u00e9lev\u00e9 de maladie grave caus\u00e9e par le VRS", a d\u00e9clar\u00e9 Marks dans un communiqu\u00e9 obtenu par CNN<\/a>.<\/p>\n

"L'approbation aujourd'hui du premier vaccin contre le RSV est une r\u00e9alisation importante en mati\u00e8re de sant\u00e9 publique pour pr\u00e9venir une maladie qui peut mettre la vie en danger et refl\u00e8te l'engagement continu de la FDA \u00e0 faciliter le d\u00e9veloppement de vaccins s\u00fbrs et efficaces destin\u00e9s \u00e0 \u00eatre utilis\u00e9s aux \u00c9tats-Unis", a-t-il ajout\u00e9.<\/p>\n

Le RSV, ou virus respiratoire syncytial, est un virus respiratoire qui provoque g\u00e9n\u00e9ralement des sympt\u00f4mes l\u00e9gers ressemblant \u00e0 ceux du rhume. M\u00eame si la plupart des gens se r\u00e9tablissent rapidement de l'infection, le VRS peut mettre la vie en danger, en particulier chez les personnes \u00e2g\u00e9es et les nourrissons, selon le rapport. CDC<\/a>.<\/p>\n

Les sympt\u00f4mes les plus courants du VRS dans les quatre \u00e0 six jours suivant l\u2019infection comprennent un \u00e9coulement nasal, une diminution de l\u2019app\u00e9tit, de la toux, des \u00e9ternuements, de la fi\u00e8vre et une respiration sifflante. Chez les nourrissons, l'infection pourrait provoquer de l'irritabilit\u00e9, une diminution de l'activit\u00e9 et des difficult\u00e9s respiratoires, selon l'agence de sant\u00e9 publique.<\/p>\n

\n
\"vaccin\"<\/picture><\/div>
\nLes personnes atteintes de trypanophobie pr\u00e9sentent des sympt\u00f4mes tels que vertiges, palpitations, insomnie, vomissements, augmentation de la pression art\u00e9rielle et attaques de panique.<\/span>
\npixabay<\/span>
\n<\/figcaption><\/figure>\n

Publi\u00e9 par Medicaldaily.com<\/p>\n

Source quotidienne m\u00e9dicale<\/a><\/p>\n

","protected":false},"excerpt":{"rendered":"

Un \u00e9v\u00e9nement monumental dans l'histoire du secteur de la sant\u00e9 s'est produit cette semaine apr\u00e8s que la Food and Drug Administration (FDA) des \u00c9tats-Unis a approuv\u00e9 le tout premier vaccin contre le VRS pour les personnes \u00e2g\u00e9es, dont la fabrication a pris six d\u00e9cennies.<\/p>\n

Mercredi, la FDA a officiellement approuv\u00e9 le vaccin contre le RSV que les scientifiques ont travaill\u00e9 dur pour d\u00e9velopper au cours des soixante derni\u00e8res ann\u00e9es, les pr\u00e9c\u00e9dentes tentatives tr\u00e8s m\u00e9diatis\u00e9es n'ayant pas vu le jour. Actualit\u00e9s ABC<\/a> signal\u00e9.<\/p>\n

GSK a d\u00e9velopp\u00e9 le premier vaccin contre le RSV approuv\u00e9 pour les personnes \u00e2g\u00e9es, Arexvy. Le groupe pharmaceutique a d\u00e9clar\u00e9 disposer d\u00e9j\u00e0 de \u00ab millions de doses pr\u00eates \u00e0 \u00eatre exp\u00e9di\u00e9es \u00bb en attendant la recommandation des Centres de contr\u00f4le et de pr\u00e9vention des maladies (CDC), attendue en juin.<\/p>\n

GSK a d\u00e9clar\u00e9 qu'il disposerait de suffisamment de doses de vaccin pour r\u00e9pondre \u00e0 la demande au moment o\u00f9 la maladie respiratoire deviendrait r\u00e9pandue au cours des saisons d'automne et d'hiver. Mais il convient de noter que Pfizer et Moderna travaillent \u00e9galement sur des vaccins similaires. Les deux pourraient \u00e9galement rejoindre le march\u00e9 peu de temps apr\u00e8s avoir re\u00e7u l\u2019approbation de la FDA.<\/p>\n

Le vaccin de Moderna est d\u00e9j\u00e0 en phase 3 d'essai. Une fois cela fait, il soumettra les r\u00e9sultats \u00e0 la FDA et attendra son approbation. Pendant ce temps, le vaccin RSV de Pfizer est d\u00e9j\u00e0 termin\u00e9. Elle n'attend plus que la d\u00e9cision de la FDA, qui pourrait \u00eatre rendue d'ici fin mai.<\/p>\n

Arexvy est con\u00e7u pour \u00eatre administr\u00e9 en une seule injection aux adultes \u00e2g\u00e9s de 60 ans et plus. Le directeur du Centre d'\u00e9valuation et de recherche sur les produits biologiques de la FDA, le Dr Peter Marks, a expliqu\u00e9 qu'il est crucial pour les personnes \u00e2g\u00e9es de recevoir ce vaccin, car elles courent un risque \u00e9lev\u00e9 de souffrir de maladies graves une fois qu'elles contractent le virus.<\/p>\n

"Les personnes \u00e2g\u00e9es, en particulier celles souffrant de probl\u00e8mes de sant\u00e9 sous-jacents, tels qu'une maladie cardiaque ou pulmonaire ou un syst\u00e8me immunitaire affaibli, courent un risque \u00e9lev\u00e9 de maladie grave caus\u00e9e par le VRS", a d\u00e9clar\u00e9 Marks dans un communiqu\u00e9 obtenu par CNN<\/a>.<\/p>\n

"L'approbation aujourd'hui du premier vaccin contre le RSV est une r\u00e9alisation importante en mati\u00e8re de sant\u00e9 publique pour pr\u00e9venir une maladie qui peut mettre la vie en danger et refl\u00e8te l'engagement continu de la FDA \u00e0 faciliter le d\u00e9veloppement de vaccins s\u00fbrs et efficaces destin\u00e9s \u00e0 \u00eatre utilis\u00e9s aux \u00c9tats-Unis", a-t-il ajout\u00e9.<\/p>\n

Le RSV, ou virus respiratoire syncytial, est un virus respiratoire qui provoque g\u00e9n\u00e9ralement des sympt\u00f4mes l\u00e9gers ressemblant \u00e0 ceux du rhume. M\u00eame si la plupart des gens se r\u00e9tablissent rapidement de l'infection, le VRS peut mettre la vie en danger, en particulier chez les personnes \u00e2g\u00e9es et les nourrissons, selon le rapport. CDC<\/a>.<\/p>\n

Les sympt\u00f4mes les plus courants du VRS dans les quatre \u00e0 six jours suivant l\u2019infection comprennent un \u00e9coulement nasal, une diminution de l\u2019app\u00e9tit, de la toux, des \u00e9ternuements, de la fi\u00e8vre et une respiration sifflante. Chez les nourrissons, l'infection pourrait provoquer de l'irritabilit\u00e9, une diminution de l'activit\u00e9 et des difficult\u00e9s respiratoires, selon l'agence de sant\u00e9 publique.<\/p>\n

\n
\"vaccin\"<\/div>
\nLes personnes atteintes de trypanophobie pr\u00e9sentent des sympt\u00f4mes tels que vertiges, palpitations, insomnie, vomissements, augmentation de la pression art\u00e9rielle et attaques de panique.<\/span>
\npixabay<\/span>
\n<\/figcaption><\/figure>\n

Publi\u00e9 par Medicaldaily.com<\/p>","protected":false},"author":2,"featured_media":8170,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"page_builder":"","fifu_image_url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","fifu_image_alt":"","footnotes":""},"categories":[27],"tags":[198,193],"class_list":["post-8169","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","tag-blood-pressure","tag-vaccination"],"yoast_head":"\nFirst RSV Vaccine Approved After Six Decades: 'Important Public Health Achievement' - Urban Care Clinic<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/urbancare.clinic\/fr\/premier-vaccin-rsv-approuve-apres-six-decennies-dimportantes-realisations-en-matiere-de-sante-publique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"First RSV Vaccine Approved After Six Decades: 'Important Public Health Achievement' - Urban Care Clinic\" \/>\n<meta property=\"og:description\" content=\"A monumental event in the healthcare industry's history happened this week after the U.S. Food and Drug Administration (FDA) approved the first-ever RSV vaccine for older adults, which took six decades to make.On Wednesday, the FDA officially approved the RSV vaccine that scientists worked hard to develop in the past sixty years, with previous high-profile attempts not seeing the light of the day, ABC News reported.GSK developed the first approved RSV vaccine for older adults, Arexvy. The pharmaceutical company said it already has "millions of doses ready to be shipped" while waiting for the recommendation by the Centers for Disease Control and Prevention (CDC), due in June.GSK said it would have enough vaccine doses to meet the demand by the time the respiratory illness becomes prevalent during the fall and winter seasons. But it's worth noting that Pfizer and Moderna are also working on similar vaccines. The two could join the market soon after receiving the FDA's approval as well.Moderna's vaccine is already in its Phase 3 trial. Once done, it will submit the results to the FDA and wait for approval. Meanwhile, Pfizer's RSV vaccine is already complete. It is only waiting for the FDA's decision, which could come out by the end of May.Arexvy is designed to be administered as a single shot to adults aged 60 and above. FDA's Center for Biologics Evaluation and Research director Dr. Peter Marks explained that it's crucial for older adults to get this vaccine because they are at a high risk of suffering from serious conditions once they contract the virus."Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV," Marks said in a statement obtained by CNN."Today's approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening and reflects the FDA's continued commitment to facilitating the development of safe and effective vaccines for use in the United States," he added.RSV, or respiratory syncytial virus, is a respiratory virus that causes typically mild, cold-like symptoms. While most people recover quickly from the infection, RSV can be life-threatening, especially for older adults and infants, according to the CDC.The most common symptoms of RSV within four to six days after getting infected include a runny nose, a decrease in appetite, coughing, sneezing, fever and wheezing. In infants, the infection could cause irritability, decreased activity and breathing difficulties, as per the public health agency. People with Trypanophobia show symptoms like dizziness, palpitations, insomnia, vomiting, increased blood pressure, and panic attacks. pixabay Published by Medicaldaily.com\" \/>\n<meta property=\"og:url\" content=\"https:\/\/urbancare.clinic\/fr\/premier-vaccin-rsv-approuve-apres-six-decennies-dimportantes-realisations-en-matiere-de-sante-publique\/\" \/>\n<meta property=\"og:site_name\" content=\"Urban Care Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/urbancarezanzibar\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T23:33:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-05-23T14:37:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Urban Care Clinic\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Urban Care Clinic\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\"},\"author\":{\"name\":\"Urban Care Clinic\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\"},\"headline\":\"First RSV Vaccine Approved After Six Decades: ‘Important Public Health Achievement’\",\"datePublished\":\"2023-05-04T23:33:32+00:00\",\"dateModified\":\"2023-05-23T14:37:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\"},\"wordCount\":472,\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\",\"keywords\":[\"Blood Pressure\",\"Vaccination\"],\"articleSection\":[\"Medical Daily\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\",\"name\":\"First RSV Vaccine Approved After Six Decades: 'Important Public Health Achievement' - Urban Care Clinic\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\",\"datePublished\":\"2023-05-04T23:33:32+00:00\",\"dateModified\":\"2023-05-23T14:37:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg\",\"caption\":\"First RSV Vaccine Approved After Six Decades: ‘Important Public Health Achievement’\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/urbancare.clinic\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"First RSV Vaccine Approved After Six Decades: ‘Important Public Health Achievement’\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#website\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"name\":\"Urban Care Clinic\",\"description\":\"Your Medical Healthcare Clinic in Zanzibar\",\"publisher\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/urbancare.clinic\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#organization\",\"name\":\"Urban Care Clinic Zanzibar\",\"alternateName\":\"Urban Care Clinic\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"contentUrl\":\"https:\\\/\\\/urbancare.clinic\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/Urban-Care-Clinic-Logo-Trans-512x512-1.png\",\"width\":500,\"height\":500,\"caption\":\"Urban Care Clinic Zanzibar\"},\"image\":{\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/urbancarezanzibar\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/urbancare.clinic\\\/#\\\/schema\\\/person\\\/a304a61bcf298680ee41e2e9ae193930\",\"name\":\"Urban Care Clinic\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g\",\"caption\":\"Urban Care Clinic\"},\"url\":\"https:\\\/\\\/urbancare.clinic\\\/fr\\\/author\\\/urban-care-clinic\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Premier vaccin contre le RSV approuv\u00e9 apr\u00e8s six d\u00e9cennies : \u00ab\u00a0r\u00e9alisation importante en mati\u00e8re de sant\u00e9 publique\u00a0\u00bb - Urban Care Clinic","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/urbancare.clinic\/fr\/premier-vaccin-rsv-approuve-apres-six-decennies-dimportantes-realisations-en-matiere-de-sante-publique\/","og_locale":"fr_FR","og_type":"article","og_title":"First RSV Vaccine Approved After Six Decades: 'Important Public Health Achievement' - Urban Care Clinic","og_description":"A monumental event in the healthcare industry's history happened this week after the U.S. Food and Drug Administration (FDA) approved the first-ever RSV vaccine for older adults, which took six decades to make.On Wednesday, the FDA officially approved the RSV vaccine that scientists worked hard to develop in the past sixty years, with previous high-profile attempts not seeing the light of the day, ABC News reported.GSK developed the first approved RSV vaccine for older adults, Arexvy. The pharmaceutical company said it already has \"millions of doses ready to be shipped\" while waiting for the recommendation by the Centers for Disease Control and Prevention (CDC), due in June.GSK said it would have enough vaccine doses to meet the demand by the time the respiratory illness becomes prevalent during the fall and winter seasons. But it's worth noting that Pfizer and Moderna are also working on similar vaccines. The two could join the market soon after receiving the FDA's approval as well.Moderna's vaccine is already in its Phase 3 trial. Once done, it will submit the results to the FDA and wait for approval. Meanwhile, Pfizer's RSV vaccine is already complete. It is only waiting for the FDA's decision, which could come out by the end of May.Arexvy is designed to be administered as a single shot to adults aged 60 and above. FDA's Center for Biologics Evaluation and Research director Dr. Peter Marks explained that it's crucial for older adults to get this vaccine because they are at a high risk of suffering from serious conditions once they contract the virus.\"Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV,\" Marks said in a statement obtained by CNN.\"Today's approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening and reflects the FDA's continued commitment to facilitating the development of safe and effective vaccines for use in the United States,\" he added.RSV, or respiratory syncytial virus, is a respiratory virus that causes typically mild, cold-like symptoms. While most people recover quickly from the infection, RSV can be life-threatening, especially for older adults and infants, according to the CDC.The most common symptoms of RSV within four to six days after getting infected include a runny nose, a decrease in appetite, coughing, sneezing, fever and wheezing. In infants, the infection could cause irritability, decreased activity and breathing difficulties, as per the public health agency. People with Trypanophobia show symptoms like dizziness, palpitations, insomnia, vomiting, increased blood pressure, and panic attacks. pixabay Published by Medicaldaily.com","og_url":"https:\/\/urbancare.clinic\/fr\/premier-vaccin-rsv-approuve-apres-six-decennies-dimportantes-realisations-en-matiere-de-sante-publique\/","og_site_name":"Urban Care Clinic","article_publisher":"https:\/\/www.facebook.com\/urbancarezanzibar","article_published_time":"2023-05-04T23:33:32+00:00","article_modified_time":"2023-05-23T14:37:30+00:00","og_image":[{"url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","width":1024,"height":1024,"type":"image\/jpeg"}],"author":"Urban Care Clinic","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Urban Care Clinic","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#article","isPartOf":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/"},"author":{"name":"Urban Care Clinic","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930"},"headline":"First RSV Vaccine Approved After Six Decades: ‘Important Public Health Achievement’","datePublished":"2023-05-04T23:33:32+00:00","dateModified":"2023-05-23T14:37:30+00:00","mainEntityOfPage":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/"},"wordCount":472,"publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"image":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","keywords":["Blood Pressure","Vaccination"],"articleSection":["Medical Daily"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/","url":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/","name":"Premier vaccin contre le RSV approuv\u00e9 apr\u00e8s six d\u00e9cennies : \u00ab\u00a0r\u00e9alisation importante en mati\u00e8re de sant\u00e9 publique\u00a0\u00bb - Urban Care Clinic","isPartOf":{"@id":"https:\/\/urbancare.clinic\/#website"},"primaryImageOfPage":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#primaryimage"},"image":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#primaryimage"},"thumbnailUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","datePublished":"2023-05-04T23:33:32+00:00","dateModified":"2023-05-23T14:37:30+00:00","breadcrumb":{"@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#primaryimage","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2023\/05\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement.jpg","caption":"First RSV Vaccine Approved After Six Decades: ‘Important Public Health Achievement’"},{"@type":"BreadcrumbList","@id":"https:\/\/urbancare.clinic\/first-rsv-vaccine-approved-after-six-decades-important-public-health-achievement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/urbancare.clinic\/"},{"@type":"ListItem","position":2,"name":"First RSV Vaccine Approved After Six Decades: ‘Important Public Health Achievement’"}]},{"@type":"WebSite","@id":"https:\/\/urbancare.clinic\/#website","url":"https:\/\/urbancare.clinic\/","name":"Clinique de soins urbains","description":"Votre clinique de soins m\u00e9dicaux \u00e0 Zanzibar","publisher":{"@id":"https:\/\/urbancare.clinic\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/urbancare.clinic\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/urbancare.clinic\/#organization","name":"Clinique de soins urbains Zanzibar","alternateName":"Urban Care Clinic","url":"https:\/\/urbancare.clinic\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/","url":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","contentUrl":"https:\/\/urbancare.clinic\/wp-content\/uploads\/2022\/07\/Urban-Care-Clinic-Logo-Trans-512x512-1.png","width":500,"height":500,"caption":"Urban Care Clinic Zanzibar"},"image":{"@id":"https:\/\/urbancare.clinic\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/urbancarezanzibar"]},{"@type":"Person","@id":"https:\/\/urbancare.clinic\/#\/schema\/person\/a304a61bcf298680ee41e2e9ae193930","name":"Clinique de soins urbains","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8f8b5f9c42679ce61ae24fd31561a4574502595c4b3428a4fdf92d929bf09352?s=96&d=mm&r=g","caption":"Urban Care Clinic"},"url":"https:\/\/urbancare.clinic\/fr\/author\/urban-care-clinic\/"}]}},"_links":{"self":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts\/8169","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/comments?post=8169"}],"version-history":[{"count":0,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/posts\/8169\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/media\/8170"}],"wp:attachment":[{"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/media?parent=8169"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/categories?post=8169"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urbancare.clinic\/fr\/wp-json\/wp\/v2\/tags?post=8169"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}